Parathyroid Neoplasms

• CLINICAL_TRIALS research · 2026-04-24
  Clinical Trial Update: Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

  This clinical trial aims to perform a comprehensive molecular analysis of endocrine neoplasms and is currently recruiting.

• CLINICAL_TRIALS trial_result · 2025-08-27
  Clinical Trial Update: Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy [NA]

  The clinical trial evaluating near-infrared autofluorescence to identify parathyroid glands during parathyroidectomy has completed, and resu…

• CLINICAL_TRIALS research · 2025-06-29
  Clinical Trial Update: WHITE CAP: Intra-operative Parathyroid Tissue Sensor (PTS)-Guided Assessment of Parathyroid Viability and Surgical Decision-Making [NA]

  The registry entry describes the WHITE CAP study evaluating intra-operative Parathyroid Tissue Sensor guidance to assess parathyroid viabili…

• EMA approval · 2024-06-06
  EMA Authorised: Mimpara (cinacalcet hydrochloride) — Amgen Europe B.V.

  The European Medicines Agency authorised Mimpara (cinacalcet hydrochloride) for indications including hypercalcemia, parathyroid neoplasms, …

• CLINICAL_TRIALS trial_result · 2024-05-13
  Clinical Trial Update: Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy [NA]

  A completed clinical trial evaluated the impact of near-infrared auto-fluorescence (NIRAF) detection for identifying parathyroid glands duri…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2024-03-21
  Clinical Trial Update: Lidocaine And Neuromonitoring in Thyroid Surgery [Phase 4]

  Phase 4 clinical trial update examining lidocaine use and neuromonitoring during thyroid surgery completed.

• CLINICAL_TRIALS trial_result · 2013-05-08
  Clinical Trial Update: A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer [Phase 4]

  Amgen conducted a Phase 4 trial of an investigational medication for severe primary hyperparathyroidism and parathyroid neoplasms; the study…

• CLINICAL_TRIALS trial_result · 2011-04-27
  Clinical Trial Update: Evaluation of MRI and SPECT Fusion Software to Localize Parathyroid Adenomas

  A terminated clinical trial evaluated MRI and SPECT fusion software to localize parathyroid adenomas. The study was sponsored by State Unive…

• EMA withdrawal · 2009-05-14
  EMA Withdrawn: Parareg (cinacalcet) — Dompé Biotec S.p.A.

  EMA withdrawn status for Parareg (cinacalcet) by Dompé Biotec S.p.A., with therapeutic areas including hypercalcemia, parathyroid neoplasms,…

• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: Using X-Ray Dye to Locate Hidden Parathyroid Tumors

  A completed clinical trial evaluated using an X-ray dye to locate hidden parathyroid tumors. The study was sponsored by the National Institu…